Aldeyra Therapeutics Inc Call to Report Top-Line Results from the Crossover Clinical Trial of Reproxalap Transcript

Jul 12, 2022 / 12:00PM GMT
Operator

Good morning, and welcome to the Aldeyra Therapeutics conference call. (Operator Instructions)

I would now like to hand the conference call over to Bruce Greenberg, Vice President of Finance, Interim Chief Financial Officer and Treasurer. Thank you. Sir, please go ahead.

Bruce Greenberg - Aldeyra Therapeutics, Inc. - VP of Finance, Interim CFO & Treasurer

Thank you, and good morning, everyone. With me are President and Chief Executive Officer, Dr. Todd Brady; and Kelly Mizer, our Vice President of Commercial Strategy and Operations. Joining us on today's call is Dr. John Berdahl, a specialist in diseases of the anterior segment at Vance Thompson Vision and Professor of Ophthalmology at the Stanford School of Medicine.

This morning, we issued a press release reporting top-line results for the Crossover clinical trial of reproxalap for the treatment of dry eye disease. A copy of the press release is available on the Investors & Media section of our website, www.aldeyra.com.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot